Akylox Therapeutics ApS
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik Nordre Fasanvej 215, 2000 Frederiksberg CVR 44974045
Active
The owner has not filled in this profile yet. Data comes from CVR.
Owners and management
| Novo Holdings A/S
Ownership |
33% |
| Danmarks Eksport- og Investeringsfond
Ownership |
10% |
| Matthias Paul Wymann
Ownership |
10% |
| Alexander Thomas Hagen Flohr
Ownership |
5% |
| Dennis Gregory Gillingham
Ownership |
5% |
| Sebastian Kim Lugert
Ownership |
5% |
| Pureos Bioventures 2, LP
Ownership |
5% |
| Criteria Bio Ventures SICC S.A.
Ownership |
5% |
| Martin Bonde
ADM. DIR. |
|
| Martin Bonde
BESTYRELSESMEDLEM |
|
| Gabor Gyulveszi
FORMAND |
|
| EY Godkendt Revisionspartnerselskab
REVISION |
|
| Alexander Thomas Hagen Flohr
STIFTERE |
|
| Dennis Gregory Gillingham
STIFTERE |
|
| Matthias Paul Wymann
STIFTERE |
|
| Sebastian Kim Lugert
STIFTERE |
|
| Butrint Aliu
BESTYRELSESMEDLEM |
|
| Pablo Gabriel Cironi Lopez
BESTYRELSESMEDLEM |
Locations
Financial reports
More about this company
At the same address · Nordre Fasanvej 215
See allSame address point in the address register (DAR)
Same owners
Shared participant according to CVR — current roles only
Nearby
See allWithin 800 m — sorted by distance
Same industry nearby · Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
See allSame industry code in the same municipality
Biggest in the industry · Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
See allMost employees in the same industry code